Eleison Pharmaceuticals Inc. (ELSN)
Eleison Pharmaceuticals will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Total Valuation
Market Cap | n/a |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 1.17 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $500,000 |
Profits Per Employee | -$2.30M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Average Volume (30 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ELSN had revenue of $1.00 million and -$4.59 million in losses.
Revenue | 1.00M |
Gross Profit | 1.00M |
Operating Income | -1.47M |
Pretax Income | -4.59M |
Net Income | -4.59M |
EBITDA | -3.17M |
EBIT | -3.17M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $1.83 million in cash and $516,271 in debt, giving a net cash position of $1.31 million.
Cash & Cash Equivalents | 1.83M |
Total Debt | 516,271 |
Net Cash | 1.31M |
Net Cash Per Share | n/a |
Equity / Book Value | 440,785 |
Book Value Per Share | n/a |
Working Capital | 707,950 |
Cash Flow
Operating Cash Flow | -9.01M |
Capital Expenditures | n/a |
Free Cash Flow | -9.01M |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -146.78% and -459.09%.
Gross Margin | 100.00% |
Operating Margin | -146.78% |
Pretax Margin | -459.09% |
Profit Margin | -459.09% |
EBITDA Margin | -316.78% |
EBIT Margin | -316.78% |
FCF Margin | -901.21% |
Dividends & Yields
ELSN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |